SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,529.08 -329.91
( -0.44%)

Global Indices

Nasdaq

51,895.24 -174.59
(-0.34%)

Dow Jones

7,786.35 0.65
(0.01%)

Hang Seng

65,040.24 903.99
(1.41%)

Nikkei 225

10,723.15 -15.86
(-0.15%)

Forex

USD-INR

95.99 0.12
(0.12%)

EUR-INR

110.24 0.24
(0.22%)

GBP-INR

128.54 0.36
(0.28%)

JPY-INR

0.61 0.00
(-0.53%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Novartis India standalone net profit declines 13.82% in the March 2026 quarter

May 12,2026

Net profit of Novartis India declined 13.82% to Rs 25.25 crore in the quarter ended March 2026 as against Rs 29.30 crore during the previous quarter ended March 2025. Sales rose 7.95% to Rs 90.55 crore in the quarter ended March 2026 as against Rs 83.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 7.65% to Rs 93.18 crore in the year ended March 2026 as against Rs 100.90 crore during the previous year ended March 2025. Sales declined 0.54% to Rs 354.33 crore in the year ended March 2026 as against Rs 356.27 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	90.55	83.88	8	354.33	356.27	-1
OPM %	22.77	28.51	-	26.56	25.66	-
PBDT	30.56	34.42	-11	131.61	132.61	-1
PBT	30.14	33.89	-11	129.66	130.42	-1
NP	25.25	29.30	-14	93.18	100.90	-8

74,529.08 -329.91 ( -0.44%)

51,895.24 -174.59 (-0.34%)

7,786.35 0.65 (0.01%)

65,040.24 903.99 (1.41%)

10,723.15 -15.86 (-0.15%)

95.99 0.12 (0.12%)

110.24 0.24 (0.22%)

128.54 0.36 (0.28%)

0.61 0.00 (-0.53%)